- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pertuzumab
Total 455 results
-
Nantes University HospitalCompleted
-
Stichting Hemato-Oncologie voor Volwassenen NederlandCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Fudan UniversityActive, not recruiting
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
The University of Hong Kong-Shenzhen HospitalTianjin Happy Life Technology Co., Ltd.Not yet recruitingFeasibility | Safety | Targeted Molecular Therapy | Effectiveness
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio... and other collaboratorsCompletedBreast CancerUnited States
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
The Greater Poland Cancer CentreActive, not recruiting
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid LeukemiaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Sweden
-
University of UlmCompletedLeukemia, Myeloid, AcuteGermany, Austria
-
University of Maryland, BaltimoreHematologics, IncRecruitingAcute Myeloid Leukemia Recurrent | Acute Myeloid Leukemia, Adult | Acute Myeloid Leukemia, Relapsed, AdultUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada, Australia
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
Hoffmann-La RocheCompleted
-
Shengjing HospitalRecruitingStage II-III Breast CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Gustave Roussy, Cancer Campus, Grand ParisHoffmann-La RocheRecruiting
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Dana-Farber Cancer InstituteMacroGenics; Translational Breast Cancer Research ConsortiumRecruitingBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast NeoplasmsItaly, Netherlands, Belgium, United Kingdom, Argentina, Austria, Brazil, China, Ecuador, Estonia, Finland, France, Germany, Greece, Mexico, Peru, Poland, Portugal, Slovenia, Spain, United Arab Emirates, Canada, Hungary, Israel, Sweden, Tu... and more
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedNeuroendocrine CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Samsung Medical CenterUnknownAcute Myeloid LeukemiaKorea, Republic of
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
National Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Stage III Colon Cancer | Stage III Rectal Cancer | Adenocarcinoma of the ColonUnited States
-
Baylor College of MedicineWilliam Marsh Rice UniversityActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCSPC Ouyi Pharmaceutical Co., Ltd.Recruiting
-
Eli Lilly and CompanyCoLucid PharmaceuticalsCompleted
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Hoffmann-La RocheCompletedGastric CancerAustria, Belgium, Brazil, Canada, China, Croatia, Finland, Hungary, Italy, Korea, Republic of, Mexico, Poland, Spain, Turkey, United States, Kazakhstan, Peru, Russian Federation, Switzerland, Taiwan, Thailand, Germany, Japan, Malaysia, ... and more
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles; Pfizer; Jazz PharmaceuticalsTerminatedAcute Myelogenous LeukemiaUnited States
-
Genentech, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Genentech, Inc.CompletedAdvanced Unresectable or Metastatic Solid MalignancyUnited States
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Women and Infants Hospital of Rhode...CompletedBreast CancerUnited States
-
Qilu Pharmaceutical Co., Ltd.Completed
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting